Nifty
Sensex
:
:
23587.50
78041.59
-364.20 (-1.52%)
-1176.46 (-1.49%)

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 524774 | NSE: NGLFINE

1980.45
23-Dec-2024
  • Open
  • High
  • Low
  • Previous Close
  •  2050.80
  •  2050.80
  •  1945.10
  •  2040.05
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1227
  •  24.38
  •  2823.90
  •  1702.35

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,253.12
  • 30.28
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,292.92
  • 0.09%
  • 4.47

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 72.74%
  • 1.92%
  • 21.69%
  • FII
  • DII
  • Others
  • 0.02%
  • 0.00%
  • 3.63%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.05
  • 17.43
  • 2.18

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.58
  • 22.15
  • -4.65

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.55
  • 37.72
  • -6.10

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 31.44
  • 31.44
  • 34.80

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.98
  • 5.98
  • 5.28

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 19.45
  • 19.45
  • 20.83

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
93.48
80.18
16.59%
90.75
71.04
27.74%
99.76
73.89
35.01%
87.95
71.94
22.25%
Expenses
81.93
66.21
23.74%
81.40
61.18
33.05%
83.94
60.92
37.79%
74.08
62.12
19.25%
EBITDA
11.56
13.97
-17.25%
9.35
9.86
-5.17%
15.82
12.97
21.97%
13.87
9.81
41.39%
EBIDTM
12.36%
17.42%
10.30%
13.88%
15.86%
17.56%
15.77%
13.64%
Other Income
5.12
3.22
59.01%
5.88
3.32
77.11%
3.68
2.10
75.24%
3.68
0.69
433.33%
Interest
0.32
0.36
-11.11%
0.44
0.24
83.33%
0.49
0.34
44.12%
0.28
0.26
7.69%
Depreciation
3.03
2.89
4.84%
3.00
2.86
4.90%
2.92
2.68
8.96%
2.94
1.23
139.02%
PBT
13.33
13.94
-4.38%
11.79
10.08
16.96%
16.09
12.05
33.53%
14.33
9.01
59.05%
Tax
3.52
3.46
1.73%
2.57
1.58
62.66%
3.77
2.73
38.10%
4.29
2.53
69.57%
PAT
9.81
10.48
-6.39%
9.22
8.51
8.34%
12.32
9.32
32.19%
10.03
6.49
54.55%
PATM
10.50%
13.07%
10.16%
11.97%
12.35%
12.62%
11.41%
9.02%
EPS
15.88
16.96
-6.37%
14.92
13.77
8.35%
19.95
15.09
32.21%
16.24
10.50
54.67%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Net Sales
371.94
338.69
278.08
317.50
257.97
151.69
153.17
Net Sales Growth
25.21%
21.80%
-12.42%
23.08%
70.06%
-0.97%
 
Cost Of Goods Sold
179.90
158.68
140.32
146.99
102.34
64.36
62.63
Gross Profit
192.04
180.00
137.76
170.51
155.63
87.32
90.54
GP Margin
51.63%
53.15%
49.54%
53.70%
60.33%
57.56%
59.11%
Total Expenditure
321.35
284.95
243.12
249.31
177.87
131.93
120.88
Power & Fuel Cost
-
23.25
18.53
16.29
10.15
10.30
9.02
% Of Sales
-
6.86%
6.66%
5.13%
3.93%
6.79%
5.89%
Employee Cost
-
45.12
36.87
34.85
28.09
24.04
21.16
% Of Sales
-
13.32%
13.26%
10.98%
10.89%
15.85%
13.81%
Manufacturing Exp.
-
31.41
24.14
28.94
18.22
17.22
13.21
% Of Sales
-
9.27%
8.68%
9.11%
7.06%
11.35%
8.62%
General & Admin Exp.
-
10.55
8.79
6.23
5.11
6.11
5.33
% Of Sales
-
3.11%
3.16%
1.96%
1.98%
4.03%
3.48%
Selling & Distn. Exp.
-
10.38
8.23
11.28
7.33
4.64
4.58
% Of Sales
-
3.06%
2.96%
3.55%
2.84%
3.06%
2.99%
Miscellaneous Exp.
-
5.55
6.25
4.72
6.61
5.25
4.95
% Of Sales
-
1.64%
2.25%
1.49%
2.56%
3.46%
3.23%
EBITDA
50.60
53.74
34.96
68.19
80.10
19.76
32.29
EBITDA Margin
13.60%
15.87%
12.57%
21.48%
31.05%
13.03%
21.08%
Other Income
18.36
14.13
5.53
10.68
8.02
3.05
4.12
Interest
1.53
1.81
1.83
1.91
2.20
2.63
2.55
Depreciation
11.89
11.64
11.29
10.37
8.33
8.11
6.30
PBT
55.54
54.42
27.36
66.60
77.59
12.07
27.57
Tax
14.15
13.10
6.87
16.70
20.87
3.74
7.44
Tax Rate
25.48%
24.07%
25.11%
25.08%
26.90%
30.99%
26.99%
PAT
41.38
41.32
20.50
49.90
56.72
8.34
20.13
PAT before Minority Interest
41.38
41.32
20.50
49.90
56.72
8.34
20.13
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
11.13%
12.20%
7.37%
15.72%
21.99%
5.50%
13.14%
PAT Growth
18.91%
101.56%
-58.92%
-12.02%
580.10%
-58.57%
 
EPS
66.74
66.65
33.06
80.48
91.48
13.45
32.47

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Shareholder's Funds
262.63
222.55
203.22
154.46
98.96
92.12
Share Capital
3.09
3.09
3.09
3.09
3.09
3.09
Total Reserves
259.54
219.46
200.13
151.37
95.87
89.03
Non-Current Liabilities
6.32
6.24
8.06
11.16
11.62
11.90
Secured Loans
0.74
2.07
3.44
6.13
8.32
8.01
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
3.23
2.70
2.55
2.46
2.11
1.40
Current Liabilities
86.59
58.29
65.65
41.77
48.71
45.18
Trade Payables
49.39
24.59
37.16
29.53
20.83
16.12
Other Current Liabilities
3.97
3.67
4.44
6.12
6.34
5.61
Short Term Borrowings
31.70
28.41
23.43
4.83
14.60
15.31
Short Term Provisions
1.53
1.63
0.63
1.28
6.93
8.15
Total Liabilities
355.54
287.08
276.93
207.39
159.29
149.20
Net Block
85.57
87.91
88.77
64.13
67.74
60.94
Gross Block
148.11
139.39
129.53
95.96
91.81
74.07
Accumulated Depreciation
62.54
51.48
40.76
31.83
24.07
13.13
Non Current Assets
142.87
124.42
103.44
82.86
72.76
62.80
Capital Work in Progress
45.52
26.31
6.43
12.35
0.00
0.00
Non Current Investment
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
7.16
5.81
5.66
6.38
5.00
1.81
Other Non Current Assets
4.62
4.39
2.57
0.00
0.01
0.04
Current Assets
212.67
162.66
173.49
124.53
86.53
86.41
Current Investments
53.59
39.46
28.72
29.07
10.65
8.69
Inventories
43.30
26.99
56.01
37.85
27.90
18.61
Sundry Debtors
89.62
65.87
63.98
37.56
26.19
33.12
Cash & Bank
1.72
13.04
0.83
4.78
3.16
3.14
Other Current Assets
24.43
2.25
2.79
1.30
18.63
22.85
Short Term Loans & Adv.
21.07
15.04
21.17
13.97
12.17
15.61
Net Current Assets
126.08
104.36
107.84
82.76
37.82
41.23
Total Assets
355.54
287.08
276.93
207.39
159.29
149.21

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Cash From Operating Activity
20.47
35.29
13.82
27.35
20.46
8.85
PBT
54.42
27.36
66.60
77.59
12.07
27.57
Adjustment
11.76
11.53
11.33
4.73
12.16
7.87
Changes in Working Capital
-32.62
3.26
-47.40
-34.09
-0.03
-19.15
Cash after chg. in Working capital
33.57
42.15
30.52
48.22
24.20
16.29
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-13.10
-6.87
-16.70
-20.87
-3.74
-7.44
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-26.82
-27.02
-14.20
-24.57
-20.85
-9.54
Net Fixed Assets
-27.42
-28.15
-12.77
-4.41
-7.18
Net Investments
-14.13
-10.74
0.35
-18.42
-5.69
Others
14.73
11.87
-1.78
-1.74
-7.98
Cash from Financing Activity
-1.08
-1.08
-1.08
-1.08
0.00
0.00
Net Cash Inflow / Outflow
-7.43
7.18
-1.46
1.70
-0.39
-0.70
Opening Cash & Equivalents
7.83
0.64
2.10
0.40
0.79
1.49
Closing Cash & Equivalent
0.40
7.83
0.64
2.10
0.40
0.79

Financial Ratios

Standalone /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Book Value (Rs.)
425.11
360.23
328.94
250.01
160.18
149.11
ROA
12.86%
7.27%
20.61%
31.42%
5.40%
13.49%
ROE
17.03%
9.63%
27.90%
44.76%
8.72%
21.85%
ROCE
20.38%
11.96%
33.91%
53.53%
11.93%
25.25%
Fixed Asset Turnover
2.36
2.07
2.82
2.75
1.83
2.07
Receivable days
83.78
85.22
58.36
45.10
71.37
78.93
Inventory Days
37.88
54.47
53.95
46.51
55.95
44.35
Payable days
85.07
75.67
72.38
78.66
47.96
48.15
Cash Conversion Cycle
36.59
64.02
39.93
12.95
79.36
75.13
Total Debt/Equity
0.13
0.15
0.15
0.11
0.29
0.29
Interest Cover
31.07
15.92
35.81
36.21
5.60
11.82

Top Investors:

News Update:


No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.